Guohong Han - Concepedia

Author

Guohong Han

Air Force Medical University ORCID

Also Known As

A Guerrero, Domenico Ferro, G H Han, G Han, G. Han, G.H. Han, Guanzhe Han, Guo S Han, Guo-Hong Han, Guo-hong Han

290

Publications

18.9K

Citations

H-Index

Concepts

All Affiliations

Air Force Medical University Xijing Hospital National Clinical Research Center for Digestive Diseases Sun Yat-sen University Zhejiang University

About

Guohong Han is an author at Air Force Medical University specializing in medicine, hepatology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	38	12.4K
2	Health Sciences	13	14	9.9K
3	Public Health	2	2	174
4	Engineering	1	1	35
5	Allergy	1	1	31

Guohong Han

Publications

16.4K

Citations

H-Index

Page 1

	Year	Citations
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial Masatoshi Kudo, Richard S. Finn, Shukui Qin, The Lancet HepatologyMedicineRandomised Phase 3Clinical TrialsPathology	2018	5.3K
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial Jordi Bruix, Shukui Qin, Philippe Merle, The Lancet HepatologyMedicineSorafenib TreatmentClinical TrialsPharmacotherapy	2016	3.6K
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) Jian Zhou, Hui‐Chuan Sun, Zheng Wang, Liver Cancer	2020	813
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial Riccardo Lencioni, Josep M. Llovet, Guohong Han, Journal of Hepatology Doxorubicin-eluting BeadsIntermediate Stage HccPharmacologyClinical TrialsPharmacotherapy	2016	680
The role of hepatic resection in the treatment of hepatocellular cancer Sasan Roayaie, Ghalib Jibara, Parissa Tabrizian, Hepatology Surgical OncologyGastroenterologyMultimodalitySurgeryHepatic Disorders	2015	402
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition) Jian Zhou, Hui‐Chuan Sun, Zheng Wang, Liver Cancer	2023	389
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial Masatoshi Kudo, Guohong Han, Richard S. Finn, Hepatology	2014	342
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study Qiuhe Wang, Dongdong Xia, Wei Bai, Journal of Hepatology Prognostic BiomarkersHepatologyMedicineRecommended Tace CandidatesPathology	2019	252
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis Guohong Han, Xingshun Qi, Chuangye He, Journal of Hepatology VaricesUrologyVenous DiseaseHepatologySymptomatic Portal Hypertension	2010	227
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial Yong Lv, Zhiping Yang, Lei Liu, The Lancet. Gastroenterology & hepatology VaricesHepatologyPatient SafetyVascular SurgeryEarly Tips	2019	222

Page 1